Your browser doesn't support javascript.
loading
18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition.
Reeves, Kirsten M; Song, Patrick N; Angermeier, Allyson; Della Manna, Deborah; Li, Yufeng; Wang, Jianbo; Yang, Eddy S; Sorace, Anna G; Larimer, Benjamin M.
Affiliation
  • Reeves KM; Department of Radiology. The University of Alabama at Birmingham, Birmingham, Alabama.
  • Song PN; O'Neal Comprehensive Cancer Center. The University of Alabama at Birmingham, Birmingham, Alabama.
  • Angermeier A; Graduate Biomedical Science Program. The University of Alabama at Birmingham, Birmingham, Alabama.
  • Della Manna D; Department of Radiology. The University of Alabama at Birmingham, Birmingham, Alabama.
  • Li Y; Graduate Biomedical Science Program. The University of Alabama at Birmingham, Birmingham, Alabama.
  • Wang J; O'Neal Comprehensive Cancer Center. The University of Alabama at Birmingham, Birmingham, Alabama.
  • Yang ES; Cell, Developmental and Integrative Biology. The University of Alabama at Birmingham, Birmingham, Alabama.
  • Sorace AG; O'Neal Comprehensive Cancer Center. The University of Alabama at Birmingham, Birmingham, Alabama.
  • Larimer BM; Radiation Oncology. The University of Alabama at Birmingham, Birmingham, Alabama.
Clin Cancer Res ; 28(2): 327-337, 2022 01 15.
Article in En | MEDLINE | ID: mdl-34615724

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article